Advertisement
Review Article| Volume 5, ISSUE 1, P41-53, May 2023

Download started.

Ok

Mild Cognitive Impairment in Older Adults

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Family Practice Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kasper S.
        • Bancher C.
        • Eckert A.
        • et al.
        Management of mild cognitive impairment (MCI): the need for national and international guidelines.
        World J Biol Psychiatry. 2020; 21: 579-594
        • Petersen R.C.
        Mild cognitive impairment.
        N Engl J Med. 2011; 364: 2227-2234
        • Jongsiriyanyong S.
        • Limpawattana P.
        Mild cognitive impairment in clinical practice: a review article.
        Am J Alzheimers Dis Other Demen. 2018; 33: 500-507
        • Mufson E.J.
        • Counts S.E.
        • Perez S.E.
        • et al.
        Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.
        Expert Rev Neurother. 2008; 8: 1703-1718
      1. 2022 Alzheimer's disease facts and figures.
        Alzheimer's Dement. 2022; 18: 700-789
        • Stokin G.B.
        • Krell-Roesch J.
        • Petersen R.C.
        • et al.
        Mild neurocognitive disorder: an old wine in a new bottle.
        Harv Rev Psychiatry. 2015; 23: 368-376
        • Ward A.
        • Tardiff S.
        • Dye C.
        • et al.
        Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature.
        Dement Geriatr Cogn Dis Extra. 2013; 3: 320-332
        • American Psychiatric Association
        Neurocognitive disorders. Diagnostic and Statistical Manual of Mental Disorders: DSM 5. 5th edition. Arlington VA, 2013: 591-644
        • Tomino C.
        • Ilari S.
        • Solfrizzi V.
        • et al.
        Mild cognitive impairment and mild dementia: the role of ginkgo biloba (EGb 761®).
        Pharmaceuticals. 2021; 14: 305
        • Ma L.
        Depression, anxiety, and apathy in mild cognitive impairment: current perspectives.
        Front Aging Neurosci. 2020; 12: 9
        • Jack Jr., C.R.
        • Knopman D.S.
        • Jagust W.J.
        • et al.
        Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
        Lancet Neurol. 2010; 9: 119-128
        • Angevaare M.J.
        • Vonk J.M.J.
        • Bertola L.
        • et al.
        Predictors of incident mild cognitive impairment and its course in a diverse community-based population.
        Neurology. 2022; 98: e15-e26
        • Sachdev P.S.
        • Lipnicki D.M.
        • Kochan N.A.
        • et al.
        The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC collaboration.
        PLoS One. 2015; 10: e0142388
        • Mufson E.J.
        • Binder L.
        • Counts S.E.
        • et al.
        Mild cognitive impairment: pathology and mechanisms.
        Acta Neuropathol. 2012; 123: 13-30
        • Petersen R.C.
        • Roberts R.O.
        • Knopman D.S.
        • et al.
        Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging.
        Neurology. 2010; 75: 889-897
        • National Institute of Health
        What is mild cognitive impairment.
        2021 (Available at:) (Accessed January 08, 2023)
        • Iraniparast M.
        • Shi Y.
        • Wu Y.
        • et al.
        Cognitive reserve and mild cognitive impairment: predictors and rates of reversion to intact cognition vs progression to dementia.
        Neurology. 2022; 98: e1114-e1123
        • Howard R.
        Subjective cognitive decline: what is it good for?.
        Lancet Neurol. 2020; 19: 203-204
      2. Centers for Disease Control and Prevention (CDC). Subjective cognitive decline. 2019 (Available at:) (Accessed January 08, 2023)
        • Petersen R.C.
        • Smith G.E.
        • Waring S.C.
        • et al.
        Aging, memory, and mild cognitive impairment.
        Int Psychogeriatr. 1997; 9: 65-69
        • Langa K.M.
        • Levine D.A.
        The diagnosis and management of mild cognitive impairment: a clinical review.
        JAMA. 2014; 312 (2551-1561)
        • Snyderman D.
        • Rovner B.W.
        Mental status examination in primary care: a review.
        Am Fam Physician. 2009; 80: 809-814
        • National Institute of Aging
        How biomarkers help diagnose dementia.
        2022 (Available at:) (Accessed January 08, 2023)
      3. The Centre for Addiction and Mental Health. Anxiety in Older Adults. 2023 (Available at:) (Accessed January 08, 2023)
      4. American Psychological Association. PTSD Assessment Instruments. 2018 (Available at:) (Accessed January 08, 2023)
      5. American Psychological Association. Depression Assessment Instruments. 2019 (Available at:) (Accessed January 08, 2023)
        • Agency for Healthcare Research and Quality
        Brown Bad Medication Review.
        (Available at:) (Accessed January 08, 2023)
        • Craft S.
        • Raman R.
        • Chow T.W.
        • et al.
        Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial.
        JAMA Neurol. 2020; 77: 1099-1109
        • Petersen R.C.
        • Lopez O.
        • Armstrong M.J.
        • et al.
        Practice guideline update summary: Mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology.
        Neurology. 2018; 90: 126-135
        • van Dyck C.H.
        • Swanson C.J.
        • Aisen P.
        • et al.
        Lecanemab in Early Alzheimer's disease [published online ahead of print, 2022 Nov 29].
        N Engl J Med. 2022; https://doi.org/10.1056/NEJMoa2212948
        • Kim Y.J.
        • Han K.D.
        • Baek M.S.
        • et al.
        Association between physical activity and conversion from mild cognitive impairment to dementia.
        Alzheimer's Res Ther. 2020; 12: 136
      6. National Academies of Sciences, Engineering, and Medicine 2017. Preventing cognitive decline and dementia: a way forward. The National Academies Press, Washington, DC2017https://doi.org/10.17226/24782 (Accessed January 08, 2023)
        • Yang J.
        • Chen J.
        • Lui Y.
        • et al.
        Integrated nonpharmacological intervention for patients with MCI––a preliminary study in Shanghai, China.
        Int J Integr Care. 2022; 1: 1-10
        • Tsapanou A.
        • Papatriantafyllou J.D.
        • Yiannopoulou K.
        • et al.
        The impact of COVID-19 pandemic on people with mild cognitive impairment/dementia and on their caregivers.
        Int J Geriatr Psychiatry. 2021; 36: 583-587
        • National Institute of Aging
        What is mild cognitive impairment?.
        (Available at:) (Accessed January 08, 2023)
        • Manly J.J.
        • Tang M.X.
        • Schupf N.
        • et al.
        Frequency and course of mild cognitive impairment in a multiethnic community.
        Ann Neurol. 2008; 63: 494-506
        • Weigand A.J.
        • Bondi M.W.
        • Thomas K.R.
        • et al.
        Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.
        Neurology. 2020; 95: e2295-e2304